organ or immune system dysfunction-related conditions. Other predictors, including neurologic disorders or dementia, may warrant expanded vaccination recommendations.
INTRODUCTION
Streptococcus pneumoniae is a leading cause of morbidity and mortality worldwide, much of which is the result of serious pneumococcal infections, including pneumonia, bacteremia, and meningitis.
1,2 Although invasive pneumococcal disease, which encompasses bacteremia and meningitis, results in more than 15,000 hospitalizations and a mortality of at least 15%, much of the burden of serious pneumococcal disease is related to pneumonia. 2 In the U.S. alone, an estimated 900,000 individuals develop pneumococcal pneumonia annually, resulting in approximately 400,000 hospitalizations. 1-3 Though mortality for pneumococcal pneumonia is only 5%-7% overall, this includes less severe pneumonias managed in the outpatient setting. 5 Mortality in adults aged 65 years and older and those requiring hospitalization is approximately 15%, as these individuals may be more susceptible to complications, including development of bacteremia.
1-4
Despite the burden of pneumococcal pneumonia, studies assessing predictors of mortality associated with serious pneumococcal disease have focused primarily on patients with invasive pneumococcal disease only, excluding patients with nonbacteremic pneumonia. 1,2 As such, the purpose of this study was to identify independent predictors of mortality among unvaccinated adults with serious pneumococcal disease, including pneumonia and invasive pneumococcal disease.
METHODS

The IRB and the Research and Development Committee of the Providence Veterans Affairs
Medical Center approved this study.
The Veterans Health Administration is the largest healthcare system in the U.S., composed of 152 medical centers along with 1,400 outpatient facilities and community living centers. 10 The electronic medical record utilized by the Veterans Health Administration captures both inpatient and outpatient visits dating back to 1999. The Veterans Affairs databases have been described previously. 11, 12 An analytic database was created from numerous Veterans Affairs databases capturing patient care, including demographics, inpatient stays, outpatient visits, pharmacy dispensings and administrations, health factors, surgeries and procedures, laboratory and microbiology results, immunizations, and vital status.
Study Population
This was a national nested case-control study of Veterans aged ≥50 years requiring inpatient care
for serious pneumococcal disease (bacteremia, meningitis, pneumonia) between January 1, 2002
and December 31, 2011. 11 Adults aged ≥50 years were selected as they are at the highest risk of developing these serious pneumococcal infections. 5 Positive S. pneumoniae sputum, blood, and cerebrospinal fluid cultures were identified using microbiology datas. 11 Pneumonia was identified by positive sputum culture in addition to a pneumonia ICD-9 diagnosis code. From this cohort, individuals who had not received the pneumococcal vaccine, as determined from pharmacy, procedure, and immunization status data, within 5 years of the positive culture were selected for inclusion.
Cases were defined as those who died from any cause within 30 days of positive culture, and controls were those alive at 30 days. All available controls were included as mortality was expected to be approximately 20%, resulting in a 1:4 ratio of cases to controls, and matching was not utilized as all demographic and clinical characteristics were assessed as predictors. were all risk factors for the development of community-acquired pneumonia, increasing risk by twofold to fourfold. 34 Neurologic disorders are believed to increase the risk of developing pneumococcal disease owing to a higher likelihood of aspiration. 2 As neurologic disorders were also independent predictors of mortality in this study, and considering the infection and potential mortality prevention afforded by pneumococcal vaccination, further studies assessing the impact of pneumococcal vaccination on outcomes in patients with a history of neurologic disorders are warranted.
25-27,33
Fluid and electrolyte disorders, chronic pressure ulcers, and MRSA or Gram-negative infections were also predictive of mortality. Fluid and electrolyte disorders, which may also be related to renal dysfunction, were predictive both during hospitalization as well as within 1 year of culture.
Other studies have previously demonstrated the risk of mortality associated with renal impairment of all severities. 35, 36 However, upon further analysis of the results of this study, diagnosis codes for renal dysfunction were present less than 20% of the time when fluid and electrolyte disorders were also present. Thus, mortality in patients with fluid and electrolyte disorders may be linked to conditions not related to renal impairment, although determining these associations is difficult solely based on diagnosis codes. More research regarding fluid and electrolyte disorders and pneumococcal disease outcomes is needed.
Chronic pressure ulcers, though predictive of mortality in this study, have also been shown to be predictive of mortality regardless of pneumococcal infection. 37 A study of 258 hospitalized patients demonstrated that risk of death more than tripled in the setting of pressure ulcers. 37 As such, the findings from this study of increased mortality in patients with pressure ulcers likely demonstrate the frail nature of older patients. With regard to history of either MRSA or Gramnegative infections, a plausible association with mortality is difficult to establish, as these diagnosis codes encompassed infections of all sources and severities.
This study also demonstrated that dementia was predictive of mortality. Dementia has been shown to increase risk of developing pneumococcal infection as well as increased disease severity, likely due to an increased risk of aspiration similar to neurologic disorders. 2, 34, 38 A retrospective study of more than 1,000 patients with a mean age of 64 years showed that dementia was an independent predictor of increased pneumococcal infection severity (OR=4.23, 95% CI=1.24, 14.4), but was not a significant predictor of mortality. 38 However, severe infection, which was assessed in the aforementioned study as well as in this study via invasive disease and intensive care unit treatment, was predictive of mortality. Although dementia was only significant in the predictive model during hospitalization, the results of this study support the already identified association between dementia and poor outcomes in the setting of pneumococcal infection. Furthermore, at least 4% of patient's with Alzheimer dementia, the most common type of dementia, are younger than age 65 years, and therefore not covered by the ACIP vaccination recommendation for individuals aged 65 years and older. 39 Thus, pneumococcal vaccination may minimize poor outcomes and prevent infection in this at-risk population; however, further research is warranted.
The strongest and most prevalent predictors of mortality were those consistent with organ dysfunction or immunodeficiency during the admission. Predictors that were present within 1 year of the infection appear to have an attenuated effect on mortality in relation to those predictors present during the index admission. Examples of this attenuation include metastatic malignancy, hepatic dysfunction of all severities, myocardial infarction, and neurologic disorders. This may be reflective of exacerbated or poorly controlled chronic conditions, such as hepatic dysfunction, in the setting of infection. Other complications, including myocardial infarction, have been shown to be strong predictors of short-term mortality in the setting of pneumonia, with increased risk of mortality still present at 1 year. 6 As such, the attenuated but still present risk of mortality attributable to myocardial infarction in this study may reflect an overall poor prognosis of this group of patients.
Limitations
There were several limitations to this study. This study did not account for resistant S.
pneumoniae isolates or the impact of antibiotic treatment on 30-day mortality. However, a mortality rate of 14% for pneumonia and 24% for invasive disease in this study is similar to that reported for elderly and hospitalized individuals reported in the literature. 1,2,6,7 As such, it is likely that the majority of patients in this cohort received appropriate antibiotic therapy. Also, the number of cases of pneumonia identified likely underestimates the actual number of cases, as the inclusion criteria for this study required both a diagnosis code and positive sputum culture. Next, although patients who received a pneumococcal vaccine within 5 years of infection were excluded, some patients may have been vaccinated prior to that 5-year period. Others have used this same definition as the impact of vaccination beyond 5 years in an elderly population is controversial, as the elderly exhibit decreased antibody activity over time against S. pneumoniae after vaccination. 40, 41 Further, it is possible that some patients did not report vaccinations they received outside of the Veterans Affairs healthcare system to their Veterans Affairs provider;
however, this potential misclassification is likely to be low, as the vaccination rate in the overall Veterans Affairs cohort with pneumococcal infection was similar to a community population with serious pneumococcal infections (33% vs 38%). 42 Extrapolation of these results to the general population is also limited, as the population primarily consisted of older white men.
Furthermore, the Veteran population is generally considered to have poorer health status in comparison with the general population, which may also limit generalizability. 43 Lastly, benefits from herd immunity through vaccination of children against pneumococcal disease could not be determined in this study.
CONCLUSIONS
This study identified independent predictors of mortality in a large cohort of unvaccinated Veterans with serious pneumococcal disease. These included several conditions that are already recognized by ACIP as recommendations for vaccination, including organ dysfunction and immunodeficiency. These results also suggest that individuals with neurologic disorders or dementia may also benefit from pneumococcal vaccination; however, further research is warranted. 
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